Bacteria in the Large Intestine Play Positive Role in Weight Management

waistline.jpg

07 Jun 2010 --- The Dutch research shows that short-chain fatty acids, in particular propionic acid, have a health benefit. After fat tissue has been exposed to propionic acid it increases the production of the satiety hormone leptin and reduces the production of another hormone, resistin.

7 Jun 2010 --- Short-chain fatty acids such as propionic acid, which are produced by bacteria in the large intestine, can improve the health status of fat tissue in the body. When fat tissue comes in contact with propionate the tissue produces the satiety hormone leptin.

This hormone makes people feel fuller, thus reducing their appetite. Propionic acid also reduces the production of resistin. Resistin improves the effectiveness of insulin. It especially appears that insulin does not function optimally in overweight people. These are the conclusions of research of Top Institute Food and Nutrition (TIFN) carried out by TNO and the University Medical Centre Groningen (UMCG).

International research shows that the activity of bacteria in the large intestine plays a important role in weight management. The bacteria in the large intestine break down food components that cannot be digested by the human body. In the process they produce short-chain fatty acids (acetic acid, propionic acid and butyric acid). These short-chain fatty acids are absorbed by the body and act as an energy source for a variety of organs, such as the gut wall, liver and muscle tissue.

The Dutch research shows that short-chain fatty acids, in particular propionic acid, have a health benefit. After fat tissue has been exposed to propionic acid it increases the production of the satiety hormone leptin and reduces the production of another hormone, resistin. The influence of propionic acid on the production of these two hormones has a two-way effect on the health status of individuals who are overweight or obese. On the one hand, it leads to reduced food intake and, on the other hand, to increased insulin sensitivity. The results have been published in the European Journal of Clinical Investigation.

TIFN is investigating how to increase the production of propionic acid by bacteria in the large intestine, for instance by eating specific foods or food components.
 

Related Articles

Business News

Lakeview Equity invests in nutritional solutions provider NutriScience Innovations

11 Dec 2017 --- Lakeview Equity Partners, LLC, a US$40 million Milwaukee, US-based private equity fund, has invested in NutriScience Innovations, LLC, based in Trumbull, Connecticut, US. NutriScience is a cGMP-certified global supplier of nutritional and functional ingredients to companies that manufacture nutraceutical, pharmaceutical, food and beverage, and dietary products.

Business News

New Biopolis probiotic mix helps reduce topical steroid use by atopic dermatitis patients

07 Dec 2017 --- Biopolis, majority owned by agricultural processor and food ingredient provider Archer Daniels Midland Company (ADM), has introduced a new probiotic mix designed to reduce the need for topical steroid use by Atopic Dermatitis (AD) patients. The clinical research recently published in JAMA Dermatology, an international peer-reviewed general medical journal, shows the benefits of consuming a mix of probiotics in reducing the need for topical steroids by AD patients.

Business News

Weight management program can put Type 2 diabetes into remission finds Lancet study

06 Dec 2017 --- Type 2 diabetes can be reversed following an intensive weight management program, according to a randomized trial in adults who have had the condition for up to six years, published in The Lancet. The findings lend support to the widespread use of this type of intervention in the routine care of Type 2 diabetes across health services.

Business News

Nestle acquires Atrium for US$2.3 billion, extends consumer healthcare portfolio

06 Dec 2017 --- Nestle has agreed to acquire Canadian nutritional health products manufacturer Atrium Innovations from a group of investors led by Permira Funds for US$2.3 billion in cash. Nestle notes that the move for the company, whose 2017 sales are expected to reach almost US$700 million, supports Nestle’s pursuit of growth opportunities in consumer healthcare to complement the company's focus on its high-growth food and beverage categories.

Nutrition & Health News

Low calorie sweeteners may satisfy the desire for sweetness, suggests new review

05 Dec 2017 --- Consumption of low-calorie sweeteners may have the advantage of satisfying desire for sweetness and controlling weight to some extent, according to a review of scientific literature examining their impact on weight control. The review, carried out by Professor Peter Rogers of the University of Bristol in the UK, negatively evaluates three common anti-sweetener arguments.

More Articles
URL : http://www.nutritioninsight.com:80/headlines/Bacteria-in-the-Large-Intestine-Play-Positive-Role-in-Weight-Management.html